Latest News and Press Releases
Want to stay updated on the latest news?
-
Reports fourth quarter 2022 commercial revenue of $4.4 million Reports full year 2022 commercial revenue of $17.1 million Delivered full year 2022 recurring commercial revenue of $11.0 million,...
-
Full year 2022 commercial revenue expected to be between $17.0 million and $17.2 million Finished 2022 with approximately $140 million in cash and investments providing runway at least into 2026 ...
-
LOWELL, Mass., Jan. 05, 2023 (GLOBE NEWSWIRE) -- Rapid Micro Biosystems, Inc. (Nasdaq: RPID) (the “Company”), an innovative life sciences technology company providing mission critical automation...
-
Reports third quarter 2022 commercial revenue of $4.7 million Delivered year-over-year recurring revenue growth of 34% Reaffirms full year 2022 commercial revenue guidance of at least $17.0 million ...
-
LOWELL, Mass., Nov. 02, 2022 (GLOBE NEWSWIRE) -- Rapid Micro Biosystems, Inc. (Nasdaq: RPID) (the “Company”), an innovative life sciences technology company providing mission critical automation...